Search Results

Filter
  • 1-10 of  1,630 results for ""COVID-19 vaccines""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults.

  • Authors : Hu H; Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.; Ma F

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage SARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2024 May 31; Vol. 42 (15), pp. 3522-3528. Date of Electronic Publication: 2024 May 03.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Factors associated with SARS-CoV-2 vaccine hesitancy after stroke: a cross-sectional study.

  • Authors : Hu P; Department of Rehabilitation, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Zhu YH

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: BMC public health [BMC Public Health] 2024 May 26; Vol. 24 (1), pp. 1401. Date of Electronic Publication: 2024 May 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458

Record details

×
Academic Journal

Efficacy and safety of inactivated SARS-CoV-2 vaccination in COVID-19-associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real-world retrospective observational study.

  • Authors : Liu S; Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Nanjing, China.; Jin Z

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/immunology

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 May; Vol. 27 (5), pp. e15166.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

×
Academic Journal

Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China.

  • Authors : Zhao XJ; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.; Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology COVID-19 breakthrough infectionsSARS-CoV-2 variants

  • Source: Journal of medical virology [J Med Virol] 2024 May; Vol. 96 (5), pp. e29640.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

×
Academic Journal

Survival and safety analysis of COVID-19 vaccine in Chinese patients with non-small cell lung cancer.

  • Authors : Xu W; Department of Medical Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.; Department of Medical Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/mortality ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/therapy ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e7032.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Enhancing vaccination uptake through community engagement: evidence from China.

  • Authors : Guan H; Center for Experimental Economics in Education, Shaanxi Normal University, Xian, 710119, China.; Zhang L

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage

  • Source: Scientific reports [Sci Rep] 2024 May 13; Vol. 14 (1), pp. 10845. Date of Electronic Publication: 2024 May 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Influence of grandchildren on COVID-19 vaccination uptake among older adults in China: a parallel-group, cluster-randomized controlled trial.

  • Authors : Bian J; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.; Zhang W

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; Grandparents*/Grandparents*/Grandparents*/psychology

  • Source: Nature aging [Nat Aging] 2024 May; Vol. 4 (5), pp. 638-646. Date of Electronic Publication: 2024 May 09.Publisher: Nature Publishing Group US Country of Publication: United States NLM ID: 101773306 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Safety and immunogenicity of heterologous boosting with a bivalent SARS-CoV-2 mRNA vaccine (XBB.1.5/BQ.1) in Chinese participants aged 18 years or more: A randomised, double-blinded, active-controlled phase 1 trial.

  • Authors : Su YW; National Vaccine Innovation Platform, Sir Run Run Hospital, Nanjing Medical University, Nanjing 211166, Jiangsu Province, China; National Vaccine Innovation Platform, School of Pharmacy, Nanjing Medical University, Nanjing 211166, Jiangsu Province, China.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Adult

  • Source: Vaccine [Vaccine] 2024 Apr 02; Vol. 42 (9), pp. 2438-2447. Date of Electronic Publication: 2024 Mar 08.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

COVID-19 vaccination and infection status: a cross-sectional survey of patients with rheumatic diseases in China.

  • Authors : Chen C; Department of Clinical Nutrition, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.; Huang S

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/complications

  • Source: Rheumatology international [Rheumatol Int] 2024 Apr; Vol. 44 (4), pp. 703-713. Date of Electronic Publication: 2023 Oct 28.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.

  • Authors : Chen S; ARC Centre of Excellence in Population Ageing Research (CEPAR), University of New South Wales, Sydney, Australia.; School of Risk and Actuarial Studies, University of New South Wales, Sydney, Australia.

Subjects: COVID-19 Vaccines* ; Vaccines*; Child

  • Source: Infectious diseases of poverty [Infect Dis Poverty] 2024 Mar 13; Vol. 13 (1), pp. 25. Date of Electronic Publication: 2024 Mar 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101606645 Publication Model: Electronic Cited Medium: Internet ISSN: 2049-9957

Record details

×
  • 1-10 of  1,630 results for ""COVID-19 vaccines""